Banks often insist start-up business owners provide their home as security if they want finance. But the housing crisis means fewer entrepreneurs, particularly younger ones, can afford a house.

Methven hasn't received notice from a mystery investor who paid a premium for 6.4 percent of the tapware maker's shares, but takes it as a ringing endorsement of plans to grow profit

Brambles owned CHEP Pallets staff in Christchurch are striking again after FIRST Union members have voted unanimously to walk off the job at the Hornby plant today at 2pm. Striking workers have decided to march to the local shopping mall to draw attention to their struggle for equal pay with CHEP’s Auckland Wiri Plant.

On 19 July 2018 the Minister Responsible for Pike River Re-Entry, Andrew Little, signed off the Agency’s baseline Concept Plan as the basis for further detailed planning and preparatory work on required equipment and infrastructure.

As the title suggests, the prospect of a second-tier patent system in New Zealand failed to advance past first base, with the New Zealand Government halting the progress of the “Advancement Patent” following its first reading. While the prospect of New Zealand having a second-tier patent system appears all but dead and buried for now, the debate both for and against its introduction raises a valid question: Did New Zealand need a second-tier patent system?

Iconic New Zealand confectionery brand, RJ’s, has been working closely with Mondelez International to ensure the future of a Kiwi favourite.

Export prices increasing more than import prices in the June 2018 quarter led to a 0.6 percent rise in the terms of trade, Stats NZ said today.

Alliance Group is marking the next stage in its transition into a food and solutions company with the launch of a new corporate identity ahead of the co-operative’s annual farmer roadshow.

From today you will be able to pre-order a limited number of the newly minted Armistice Day coin for delivery in October, right in time for Armistice Day.

Auckland's largest non-bank property financer has over $100m to invest and is eager to support the Government’s highly anticipated KiwiBuild programme but like others in the development sector the lending company is awaiting more detail.

Fisher & Paykel Healthcare expects the cost of contesting the latest patent allegations from rival ResMed will cut annual earnings by as much as $10 million in a far-ranging dispute across multiple jurisdictions